Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Atheroprotection by Trilipix in Insulin Resistance
NCT01025492Phase 4Terminated
- Sponsor
- University of Utah
- Start
- Nov 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenofibric acid in dyslipidemia, sponsored by University of Utah. Started Nov 2009; status: terminated.
02
Drugs
fenofibric acid
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01025492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025492.